Beam Therapeutics to Present Updated Data from BEACON Phase 1/2 Trial of BEAM-101 in Sickle Cell Disease at American Society of Hematology (ASH) Annual Meeting

Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the company will present updated safety and efficacy ...

ORYZON Announces First‑Patient‑In (FPI) in RESTORE Phase Ib Trial of Iadademstat in Sickle Cell Disease

Recently approved by the European Medicines Agency, RESTORE will evaluate iadademstat’s ability to raise fetal hemoglobin (HbF) in adult patients ...
Sickle Cell Disease News

First SCD patient enrolled in Phase 1b trial of oral therapy iadademstat

The first sickle cell disease patient has been enrolled in a Phase 1b trial testing iadademstat, Oryzon Genomics' ...
The Eagle

Suspect in Charlie Kirk killing had become 'more political' and likely acted alone

OREM, Utah — A 22-year-old Utah man who was arrested and booked on murder charges in the killing of Charlie Kirk held deep disdain for the conservative activist's provocative viewpoints and indicated ...
Sickle Cell Disease News

Trial of Pociredir for SCD completes enrollment of high-dose group

A Phase 1b clinical trial testing pociredir in adults with sickle cell disease has completed enrollment of its high-dose ...
The Buffalo News

Get ready to see a lot of Allen and Mahomes on Sunday's broadcast

Josh Allen and Patrick Mahomes won’t only be competing on the field Sunday but also for the attention of viewers to the many ...